Johnson & Johnson (JNJ)
149.56
+0.44
(+0.30%)
USD |
NYSE |
Apr 23, 16:00
149.20
-0.36
(-0.24%)
Pre-Market: 07:34
Johnson & Johnson Gross Profit (Quarterly): 14.87B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 14.87B |
December 31, 2023 | 14.60B |
September 30, 2023 | 14.74B |
June 30, 2023 | 17.32B |
March 31, 2023 | 16.35B |
December 31, 2022 | 13.86B |
September 30, 2022 | 13.82B |
June 30, 2022 | 16.10B |
March 31, 2022 | 15.83B |
December 31, 2021 | 8.267B |
September 30, 2021 | 16.09B |
June 30, 2021 | 15.72B |
March 31, 2021 | 15.26B |
December 31, 2020 | 14.66B |
September 30, 2020 | 14.11B |
June 30, 2020 | 11.76B |
March 31, 2020 | 13.63B |
December 31, 2019 | 13.61B |
September 30, 2019 | 13.86B |
June 30, 2019 | 13.62B |
March 31, 2019 | 13.41B |
December 31, 2018 | 13.43B |
September 30, 2018 | 13.76B |
June 30, 2018 | 13.90B |
March 31, 2018 | 13.40B |
Date | Value |
---|---|
December 31, 2017 | 12.94B |
September 30, 2017 | 12.72B |
June 30, 2017 | 12.99B |
March 31, 2017 | 12.36B |
December 31, 2016 | 12.47B |
September 30, 2016 | 12.33B |
June 30, 2016 | 13.15B |
March 31, 2016 | 12.15B |
December 31, 2015 | 12.14B |
September 30, 2015 | 11.88B |
June 30, 2015 | 12.43B |
March 31, 2015 | 12.09B |
December 31, 2014 | 12.40B |
September 30, 2014 | 13.07B |
June 30, 2014 | 13.46B |
March 31, 2014 | 12.66B |
December 31, 2013 | 12.40B |
September 30, 2013 | 12.23B |
June 30, 2013 | 12.39B |
March 31, 2013 | 11.95B |
December 31, 2012 | 11.56B |
September 30, 2012 | 11.46B |
June 30, 2012 | 11.33B |
March 31, 2012 | 11.22B |
December 31, 2011 | 10.92B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
8.267B
Minimum
Dec 2021
17.32B
Maximum
Jun 2023
14.40B
Average
14.63B
Median
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 5.084B |
Gilead Sciences Inc | 5.024B |
Eli Lilly and Co | 7.565B |
Merck & Co Inc | 10.72B |
Shockwave Medical Inc | 177.66M |